Restatement of Previously Issued Consolidated Financial Statements | 3 Months Ended |
Mar. 31, 2015 |
Restatement of Previously Issued Consolidated Financial Statements [Abstract] | |
Restatement of Previously Issued Consolidated Financial Statements | Note 12 — Restatement of Previously Issued Consolidated Financial Statements |
|
Prior to the issuance of the Company’s 2014 consolidated financial statements, the Company concluded that its previously issued 2010, 2011, 2012 and 2013 consolidated financial statements should be restated because of a misinterpretation of the guidance around accounting for its Series A Preferred Stock issued in September 2010. |
|
Background of Restatement – As discussed further in Note 12 of Item 8. Financial Statements and Supplementary Data in the 2014 10-K, on September 21, 2010 and from time to time thereafter, the Company issued to White Deer Series A Preferred Stock, Series B Preferred Stock and warrants to purchase shares of the Company’s common stock in exchange for cash. The Series A Preferred Stock was recorded outside of permanent equity and liabilities, in the Company’s consolidated balance sheet because the settlement provisions of the warrants allowed White Deer to “net exercise” the warrants by permitting White Deer to pay the exercise price of the warrant by delivering the Series A Preferred Stock with a liquidation preference equal to the exercise price that would otherwise be due from White Deer in cash. Although the terms of the Series A Preferred Stock has a mandatory redemption date attributed to it, the Company believed this provision associated with the warrants excluded the Series A Preferred Stock from the definition of mandatorily redeemable preferred stock under FASB ASC 480, “Distinguishing Liabilities from Equity.” The Company now believes that under U.S. generally accepted accounting principles, because the warrants are detachable, and thus are separate from the Series A Preferred Stock, the features of the warrants cannot be considered when evaluating the classification of the Series A Preferred Stock, and the Company therefore believes that the Series A Preferred Stock should have been classified as a liability for all periods from its issuance date. |
|
Impact of the Restatement - The effect of the restatement on the Company’s consolidated balance sheets for each quarter and annual period end, beginning with September 30, 2010, consists of reclassifications of the Series A Preferred Stock from temporary equity to a liability. Additionally, dividends and accretion, originally taken to additional paid-in capital, have been reclassified to interest expense on the statement of operations. While these non-cash reclassifications have the effect of reducing net income (or increasing the net loss) in each period, they have no material impact on total stockholders’ equity, net income (loss) attributable to common stockholders, net income (loss) per common share or cash flows. |
|
Details of the restatement for the quarter ending March 31, 2014 are as follows: |
|
|
| | | | | | | | |
| | | | | | | | |
| For the three months ended March 31, 2014 |
| | | | | | | |
| As Reported | | Adjustment | | Restated |
| | | | | | | | |
| (in thousands, except per share data) |
| | | | | | | | |
Operating loss | $ | 703 | | $ | — | | $ | 703 |
Other income (expense) | | | | | | | | |
Loss from derivative financial instruments | | -5,115 | | | — | | | -5,115 |
Gain on investment | | 1619 | | | — | | | 1,619 |
Interest expense, net | | -3,530 | | | -1,299 | | | -4,829 |
Total | | -7,026 | | | -1,299 | | | -8,325 |
Loss before income taxes | | -6,323 | | | -1,299 | | | -7,622 |
Income taxes | | — | | | — | | | — |
Net Loss | | -6,323 | | | -1,299 | | | -7,622 |
Preferred stock dividends | | -929 | | | 929 | | | — |
Accretion of redeemable preferred stock | | -370 | | | 370 | | | — |
Net Loss attributable to common stockholders | $ | -7,622 | | $ | — | | $ | -7,622 |
Net loss per common share | | | | | | | | |
Basic | $ | -2.46 | | $ | — | | $ | -2.46 |
Diluted | $ | -2.46 | | $ | — | | $ | -2.46 |
Weighted average common shares outstanding | | | | | | | | |
Basic | | 3,102 | | | — | | | 3,102 |
Diluted | | 3,102 | | | — | | | 3,102 |
|
|
| | | | | | | | |
| For the three months ended March 31, 2014 |
| | | | | | | |
| As Reported | | Adjustment | | Restated |
| (in thousands, except per share data) |
Cash flows from operating activities | | | | | | | | |
Net loss | $ | -6,323 | | $ | -1,299 | | $ | -7,622 |
Adjustments to reconcile net loss to net cash flows from operating activities | | | | | | | | |
Depreciation, depletion and amortization | | 6,902 | | | | | | 6,902 |
Share-based and other compensation | | 968 | | | | | | 968 |
Amortization of deferred loan costs | | 129 | | | — | | | 129 |
(Gain) loss derivative financial instruments | | 5,115 | | | — | | | 5,115 |
Settlement of derivative financial instruments | | -2,507 | | | — | | | -2,507 |
Gain on disposal of assets | | -19 | | | — | | | -19 |
Gain on investment | | -1,619 | | | — | | | -1,619 |
Other non-cash changes to items affecting net loss | | 2,566 | | | 1,299 | | | 3,865 |
Changes in operating assets and liabilities | | | | | | | | — |
Accounts receivable | | -1,528 | | | — | | | -1,528 |
Accounts payable | | -1,407 | | | — | | | -1,407 |
Other | | -758 | | | — | | | -758 |
Net cash flows from operating activities | | 1,519 | | | — | | | 1,519 |
Cash flows used in investing activities | | | | | | | | |
Restricted cash | | -23 | | | — | | | -23 |
Expenditures for equipment, development and leasehold | | -4,430 | | | — | | | -4,430 |
Proceeds from sale of assets | | 59 | | | — | | | 59 |
Net cash flows used in investing activities | | -4,394 | | | — | | | -4,394 |
Cash flows from financing activities | | | | | | | | |
Proceeds from debt | | 19,000 | | | — | | | 19,000 |
Repayments of debt | | -16,000 | | | — | | | -16,000 |
Debt and equity financing costs | | -11 | | | — | | | -11 |
Net cash flows from financing activities | | 2,989 | | | — | | | 2,989 |
Net increase in cash and cash equivalents | | 114 | | | — | | | 114 |
Cash and equivalents beginning of period | | 37 | | | — | | | 37 |
Cash and equivalents end of period | $ | 151 | | $ | — | | $ | 151 |
|
|
|